This ADC product is composed of an anti-PTK7 antibody conjugated via linker to auristatin (anti-PTK7-auristatin). It is in Phase I clinical trials and has demonstrated a response in Solid tumor treatment by a MOA (Mechanism of Action) of microtubules depolymerizing.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-0356CT | Recombinant Mouse anti-Human PTK7 Monoclonal antibody (EML650) | WB | |
HPAB-0027-LS | Human Anti-PTK7 Recombinant Antibody (HPAB-0027-LS) | ELISA, IB, FC, FuncS | Humanized IgG4 κ |
HPAB-0028-LS | Human Anti-PTK7 Recombinant Antibody (HPAB-0028-LS) | ELISA, FC | Human IgG |
HPAB-0029-LS | Human Anti-PTK7 Recombinant Antibody (HPAB-0029-LS) | ELISA, FC | Human IgG |
VS3-XY1318 | Mouse Anti-PTK7 Recombinant Antibody (clone 4F9) | ELISA, WB, IHC | Mouse IgG1 |
There are currently no Customer reviews or questions for ADC-118LZY. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.